Role of glia in delirium: proposed mechanisms and translational implications
Delirium is a common acute onset neurological syndrome characterised by transient fluctuations in cognition. It affects over 20% of medical inpatients and 50% of those critically ill. Delirium is associated with morbidity and mortality, causes distress to patients and carers, and has significant soc...
Main Authors: | , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Springer Nature [academic journals on nature.com]
2024
|
_version_ | 1824459354573635584 |
---|---|
author | Heffernan, ÁB Steinruecke, M Dempsey, G Chandran, S Selvaraj, BT Jiwaji, Z Stavrou, M |
author_facet | Heffernan, ÁB Steinruecke, M Dempsey, G Chandran, S Selvaraj, BT Jiwaji, Z Stavrou, M |
author_sort | Heffernan, ÁB |
collection | OXFORD |
description | Delirium is a common acute onset neurological syndrome characterised by transient fluctuations in cognition. It affects over 20% of medical inpatients and 50% of those critically ill. Delirium is associated with morbidity and mortality, causes distress to patients and carers, and has significant socioeconomic costs in ageing populations. Despite its clinical significance, the pathophysiology of delirium is understudied, and many underlying cellular mechanisms remain unknown. There are currently no effective pharmacological treatments which directly target underlying disease processes. Although many studies focus on neuronal dysfunction in delirium, glial cells, primarily astrocytes, microglia, and oligodendrocytes, and their associated systems, are increasingly implicated in delirium pathophysiology. In this review, we discuss current evidence which implicates glial cells in delirium, including biomarker studies, post-mortem tissue analyses and pre-clinical models. In particular, we focus on how astrocyte pathology, including aberrant brain energy metabolism and glymphatic dysfunction, reactive microglia, blood-brain barrier impairment, and white matter changes may contribute to the pathogenesis of delirium. We also outline limitations in this body of work and the unique challenges faced in identifying causative mechanisms in delirium. Finally, we discuss how established neuroimaging and single-cell techniques may provide further mechanistic insight at pre-clinical and clinical levels. |
first_indexed | 2025-02-19T04:40:27Z |
format | Journal article |
id | oxford-uuid:285c25b7-f1c7-4342-b152-8ae1a04220aa |
institution | University of Oxford |
language | English |
last_indexed | 2025-02-19T04:40:27Z |
publishDate | 2024 |
publisher | Springer Nature [academic journals on nature.com] |
record_format | dspace |
spelling | oxford-uuid:285c25b7-f1c7-4342-b152-8ae1a04220aa2025-02-18T20:13:18ZRole of glia in delirium: proposed mechanisms and translational implicationsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:285c25b7-f1c7-4342-b152-8ae1a04220aaEnglishJisc Publications RouterSpringer Nature [academic journals on nature.com]2024Heffernan, ÁBSteinruecke, MDempsey, GChandran, SSelvaraj, BTJiwaji, ZStavrou, MDelirium is a common acute onset neurological syndrome characterised by transient fluctuations in cognition. It affects over 20% of medical inpatients and 50% of those critically ill. Delirium is associated with morbidity and mortality, causes distress to patients and carers, and has significant socioeconomic costs in ageing populations. Despite its clinical significance, the pathophysiology of delirium is understudied, and many underlying cellular mechanisms remain unknown. There are currently no effective pharmacological treatments which directly target underlying disease processes. Although many studies focus on neuronal dysfunction in delirium, glial cells, primarily astrocytes, microglia, and oligodendrocytes, and their associated systems, are increasingly implicated in delirium pathophysiology. In this review, we discuss current evidence which implicates glial cells in delirium, including biomarker studies, post-mortem tissue analyses and pre-clinical models. In particular, we focus on how astrocyte pathology, including aberrant brain energy metabolism and glymphatic dysfunction, reactive microglia, blood-brain barrier impairment, and white matter changes may contribute to the pathogenesis of delirium. We also outline limitations in this body of work and the unique challenges faced in identifying causative mechanisms in delirium. Finally, we discuss how established neuroimaging and single-cell techniques may provide further mechanistic insight at pre-clinical and clinical levels. |
spellingShingle | Heffernan, ÁB Steinruecke, M Dempsey, G Chandran, S Selvaraj, BT Jiwaji, Z Stavrou, M Role of glia in delirium: proposed mechanisms and translational implications |
title | Role of glia in delirium: proposed mechanisms and translational implications |
title_full | Role of glia in delirium: proposed mechanisms and translational implications |
title_fullStr | Role of glia in delirium: proposed mechanisms and translational implications |
title_full_unstemmed | Role of glia in delirium: proposed mechanisms and translational implications |
title_short | Role of glia in delirium: proposed mechanisms and translational implications |
title_sort | role of glia in delirium proposed mechanisms and translational implications |
work_keys_str_mv | AT heffernanab roleofgliaindeliriumproposedmechanismsandtranslationalimplications AT steinrueckem roleofgliaindeliriumproposedmechanismsandtranslationalimplications AT dempseyg roleofgliaindeliriumproposedmechanismsandtranslationalimplications AT chandrans roleofgliaindeliriumproposedmechanismsandtranslationalimplications AT selvarajbt roleofgliaindeliriumproposedmechanismsandtranslationalimplications AT jiwajiz roleofgliaindeliriumproposedmechanismsandtranslationalimplications AT stavroum roleofgliaindeliriumproposedmechanismsandtranslationalimplications |